Journal of Oncology Research and Therapy (ISSN: 2574-710X)

Article / research article

"Distinguishing Malignant from Benign Prostate Using Chemical Elemental Content / Calcium Ratios in Prostatic Tissue"

Vladimir Zaichick1, Sofia Zaichick2*

1Radionuclide Diagnostics Department, Medical Radiological Research Centre, Koroleva Str.- 4, Obninsk 249036, Kaluga Region, Russia

2Department of Medicine, University of Illinois College of Medicine, Chicago, IL 60612, USA

*Corresponding author: Vladimir Zaichick, Radionuclide Diagnostics Department, Medical Radiological Research Centre, Koroleva Str.- 4, Obninsk 249036, Kaluga Region, Russia, Tel: +7 (48439) 60289; Fax: +7 (495) 956 1440; E-mail: vezai@obninsk.com 

Received Date: August 03, 2016; Accepted Date: September 22, 2016; Published Date: September 29, 2016

 The aim of the study was the development of new highly precise testing methods for early diagnosis of prostate cancer.For this purpose the values of Br/Ca, K/Ca, Mg/Ca, Mn/Ca, and Na/Ca mass fraction ratios in normal (n=37), benign hypertrophic (n=11) and cancerous (n=11) human prostate gland were investigated bynon-destructive instrumental neutron activation analysis with high resolution spectrometry of short-lived radionuclides (INAA-SLR). Mean values±standard error of mean (M±SΕΜ) for mass fraction ratios in the normal tissue were as follows:(Br/Ca).1021.44±0.21, K/Ca 5.69±0.38, Mg/Ca 0.511±0.045, (Mn/Ca)·103 0.623±0.062, and Na/Ca 5.58±0.48, respectively. It was observed that in benign hypertrophic tissues the Br/Ca, Mg/Ca, Mn/Ca, and Na/Ca mass fraction ratios do not differ from normal levels while the K/Ca ratio is significantly higher. In cancerous tissue the Br/Ca, K/Ca, Mn/Ca, and Na/Ca ratios are significantly higher than in normal and benign hypertrophic prostate. It was shown that the Br/Ca and Mn/Ca mass fraction ratios are the most informative for a differential diagnosis among all investigated mass fraction ratios. Finally, we propose to use the estimation of Mn/Ca mass fraction ratios in a needle-biopsy core as an accurate tool to diagnose prostate cancer. Sensitivity, specificity, and accuracy of this test were (100-9)%, (100-2)%, and (100-2)%, respectively.Obtained data allowed us to adequately evaluate the importance of chemical elemental content ratios for the diagnosis of prostate cancer.

Keywords: Chemical Elements; Chemical Elemental Mass Fraction Ratios; Prostate; Benign Prostatic Hypertrophy; Prostatic Carcinoma; Neutron Activation Analysis.

 Introduction

The prostate gland may be a source of many health problems in men past middle age, the most common being Benign Prostatic Hyperplasia (BPH), and Prostatic Carcinoma (PCa). BPH is a noncancerous enlargement of the prostate gland leading to obstruction of the urethra and can significantly impair quality of life [1]. The prevalence of histological BPH is found in approximately 50-60% of males age 40-50, in over 70% at 60 years old and in greater than 90% of men over 70 [2,3]. In many Western industrialized countries, including North America, PCa is the most frequently diagnosed form of non-cutaneous malignancy in males and, except for lung cancer, is the leading cause of death from cancer [4-9].Although the etiology of BPH and PCa is unknown, some electrolytes and trace elements have been highlighted in the literature in relation to the development of these prostate diseases [10-29].

 Electrolytes and trace elements have essential physiological functions such as maintenance and regulation of cell functionand signaling, gene regulation, activation or inhibition of enzymatic reactions, neurotransmission, and regulation of membrane function. Essential or toxic (mutagenic, carcinogenic) properties of chemical elements depend on tissue-specific need or tolerance, respectively [30]. Excessive accumulation, deficiency or an imbalance of the chemical elements may disturb the cell functions and may result in cellular degeneration, death and malignant transformation [31].

In reported studies significant changes of chemical element contents in hyperplastic and cancerous prostate in comparison with those in the normal prostatic tissue were observed [32-56].Moreover, an informative value of Zn content as a tumor marker for PCa diagnostics was shown by us [57,58]. Hence itis possible thatbesidesZn,some other chemical elements also can be usedas tumor markers for distinguish between benign and malignant prostate.

Current methods applied for measurement of chemical element contents in samples of human tissue include a number of methods. Among thesemethods the instrumental neutron activation analysis with high resolution spectrometry of short-lived radionuclides (INAA-SLR) is a non-destructive, sensitive, and prompt technique. It allows measure the chemical element contents in a few milligrams tissue without any treatment of sample. Analytical studies of the Br, Ca, K, Mg, Mn, and Na contents in normal, BPH and PCa tissue were done by us using INAA-SLR[15,21,28,50,55]. Nondestructive method of analysis avoids the possibility of changing the content of chemical elements in the studied samples [59-62], which allowed for the first time to obtain reliable results. In particular, it was shown that the average mass fraction of Ca in BPH tissue does not differ from normal level [54], but in PCa tissues it is 3.4 times lower than in healthy prostatic tissue [50]. Moreover, it was shown in our previous studies that in a normal prostate tissue mass fraction of some chemical elements tend to be correlated with Ca, while in BPH and PCa tissues these relationships are partially broken or changed [50,53,55]. Obtained results formed the basis for a new method for differential diagnosis of BPH and PCa, the essence of which was to determine the chemical elemental content / Ca content ratios in the material of trans rectal needle biopsy of prostate indurated site, because, in comparison with the absolute values of chemical element contents, using their content ratios is more suitable for diagnostics.

Therefore, the present study had three aims. The main objective was to assess the Br/Ca, K/Ca, Mg/Ca, Mn/Ca, and Na/Ca mass fraction ratios in intact prostate of healthy men aged over 40 years and in the prostate gland of age-matched patients, who had either BPH or PCa, using data about the Br, Ca, K, Mg, Mn, and Na contents obtained by INAA-SLR analysis. The second aim was to compare the levels of elemental content ratios in normal, hyperplastic, and cancerous prostate, and the third aim was to evaluate the elemental content ratios for diagnosis of prostate cancer. All studies were approved by the Ethical Committees of the Medical Radiological Research Centre, Obninsk. 

Material and Methods

Samples

All patients studied (n=22) were hospitalized in the Urological Department of the Medical Radiological Research Centre. Trans rectal puncture biopsy of suspicious indurated regions of theprostate was performed for every patient, to permit morphological study of prostatic tissue at these sites and to estimate their chemical element contents. In all cases the diagnosis has been confirmed by clinical and morphological results obtained during studies of biopsy and resected materials. The age of 11 patients with BPH ranged from 56 to 75 years, the mean being 66.8±6.5 (M±SD) years. The 11 patients aged 51-78 suffered from PCa. Their mean age was 67.7±9.9 (M±SD) years.

 Intact (Norm) prostate samples were removed at necropsy from 37 men aged 41-79 who had died suddenly. Their mean age was 55±11 (M±SD) years. The majority of deaths were due to trauma. Tissue samples were collected from the peripheral zone of dorsal and lateral lobesof their prostates, within 2 days of death and then the samples were divided into two portions. One was used for morphological study while the other was intended for chemical element analysis. A histological examination was used to control the age norm conformity, as well as to confirm the absence of microadenomatosis and latent cancer [15,21,28].

 Sample Preparation, Instrumentation, Methods and Certified Reference Materials

Details of sample preparation, the relevantnuclear reactions, radionuclides, gamma energies, methods of analysis, equipment, and the results of quality control were presented in our earlier publications concerning the chemical elements of human prostate investigated by INAA-SLR [15,21,28,50,55,63].

 Computer Programs and Statistic

A dedicated computer program for INAA mode optimization was used [64]. All prostate samples for INAA-SLR were prepared in duplicate and mean values of elemental content ratios were used in final calculation. Using the Microsoft Office Excel software, the summary of statistics, arithmetic mean, standard deviation, standard error of mean, minimum and maximum values, median, percentiles with 0.025 and 0.975 levels was calculated for chemical element mass fraction ratios in normal, benign hyperplastic and cancerous prostate tissue. The difference in the results between BPH and Norm, PCa and Norm, and PCA and BPH was evaluated by Student’s t-test. For the construction of “individual data sets for Br/Ca, K/Ca, Mg/Ca, Mn/Ca, and Na/Ca mass fraction ratios in normal, benign hypertrophic and cancerous prostate” diagrams the Microsoft Office Excel software was also used.

 Results

Table 1 presents certain statistical parameters (arithmetic mean, standard deviation, standard error of mean, minimal and maximal values, median, percentiles with 0.025 and 0.975 levels) of the Br/Ca, K/Ca, Mg/Ca, Mn/Ca, and Na/Ca mass fraction ratios in normal, benign hypertrophic and cancerous prostate.

 The ratios of means and the reliability of difference between mean values of Br/Ca, K/Ca, Mg/Ca, Mn/Ca, and Na/Ca mass fraction ratios in normal, benign hypertrophic and cancerous prostate are presented in Table 2.

Figure 1 depicts individual data sets for Br/Ca, K/Ca, Mg/Ca, Mn/Ca, and Na/Ca mass fraction ratios in all investigated samples of normal, benign hypertrophic and cancerous prostate. 

Discussion

As was shown by us [15,21,28]the use of CRM IAEA H-4 as a certified reference material for the analysis of samples of prostate tissue can be seen as quite acceptable. Good agreement of the Br, Ca, K, Mg, Mn, and Na contents analyzed by INAA-SLR with the certified data of CRM IAEA H-4 [15,21,28]indicates an acceptable accuracy of the results obtained in the study of elemental content ratios of the prostate presented in (Figure 1) (Tables 1 and 2). 

The mean values and all selected statistical parameters were calculated for 5 mass fraction ratios (Br/Ca, K/Ca, Mg/Ca, Mn/Ca, and Na/Ca) (Table 1). The mass fraction ratios of these elements were calculated for all samples of normal, BPH and PCa prostates. The results presented in Table 1 did not show substantial differences between the arithmetic means and the medians, which indicate a normal distribution of the investigated elemental content ratios. These findings allowed us to compare the means of mass fraction ratios in normal, BPH and PCa prostate using Student’s t-test. No published data referring to mass fraction ratios of chemical elements in the human prostate was found. 

From Table 2, it is observed that in benign hypertrophic tissues the Br/Ca, Mg/Ca, Mn/Ca, and Na/Ca mass fraction ratios do not differ from normal levels while the K/Ca ratio is higher (p=0.041). In cancerous tissue the Br/Ca (p=0.00019), K/Ca (p=0.000026), Mn/Ca (p=0.00051), and Na/Ca(p=0.00021) ratios are significantly higher than in normal parenchyma of the prostate. All these mass fraction ratios show similarvariations in cancerous tissues when compared with benign hypertrophic tissues of the prostate. The Mg/Ca mass fraction ratio is maintained a stable level which does not change with benign hypertrophic and malignant transformation of prostate.

Analysis of elemental content ratios in prostate tissue could become a powerful diagnostic tool. To a large extent, the resumption of the search for new methods for early diagnosis of PCa was due to experience gained in a critical assessment of the limited capacity of the prostate specific antigen (PSA) serum test [65]. In addition to the PSA serum test and morphological studyof needle-biopsy cores of the prostate, the development of other highly precise testing methods seems to be very useful. Experimental conditions of the present study were approximated to the hospital conditions as closely as possible. In all cases we analyzed a part of the material obtained from a puncture transrectal biopsy of the indurated site in the prostate. Therefore, our data allow us to evaluate adequately the importance of elemental content ratios for the diagnosis of PCa. As is evident from individual data sets (Figure 1), the Br/Ca and Mn/Ca mass fraction ratios are the most informative for a differential diagnosis. For example, if 1.2 is the value of (Mn/Ca)·103mass fraction ratio assumed to be the lower limit for PCa (Figure 1) and an estimation is made for “PCa or intact and BPH tissue”, the following values are obtained: 

Sensitivity             =              {True Positives (TP)/[TP + False Negatives (FN)]} ·100% = (100-9)%;

Specificity             =              {True Negatives (TN)/[TN + False Positives (FP)]} ·100% = (100-2)%;

Accuracy= [(TP+TN)/(TP+FP+TN+FN)] ·100% = (100-2)%. 

The number of people (samples) examined was taken into account for calculation of confidence intervals [66].In other words, if Mn/Ca mass fraction ratio in a prostate biopsy sample does not lower 1.2, one could diagnose a malignant tumor with an accuracy of (100-2)%. Thus, using the (Mn/Ca)-test makes it possible to diagnose cancer in (100-9)% cases (sensitivity). 

The same way parameters of the importance (sensitivity, specificity and accuracy) of Br/Ca mass fraction ratio for the diagnosis of PCa were calculated. If 5.0 is the values of (Br/Ca)·102mass fraction ratios assumed to be the lower limit for PCa (Figure 1) and an estimation is made for “PCa or intact and BPH tissue”, the following values are obtained: sensitivity (91±9)%, specificity (100-2)%, and accuracy (98±2)%; It should be noted, however, that Br is a component of many tranquilizers. It is possible that the increase in Br content could be explained by uncontrolled use of tranquilizers in the group of PCa patients. Therefore, for diagnostic purposes, data for Br/Ca mass fraction ratio should be used with caution.

Mass fraction ratios of Mn/Ca and Br/Ca in the needle-biopsy cores could be used as a tool to diagnose PCa and are comparable with characteristics of the Zn mass fraction-test [57,58]. However, it is our opinion that application of the elemental content ratios is more suitable for PCa diagnosis. Elemental mass fraction depends on the sample mass, which decreases with loss of its moisture. The needle-biopsy core is a small piece of tissue with a relatively high "surface/volume" ratio. After sampling, it begins to lose mass very fast. Weight loss of samples depends on the humidity of operating and store rooms [59]. Thus, it is very difficult to determine the fresh mass of needle-biopsy cores and to calculate the precise mass fraction of chemical elements. Sample freeze-dry, storage in air-tight vials until weighing, and then calculating mass fraction on dry mass basis is the only possible method that eliminates the variation in sample mass. Conversely, accuracy of elemental content ratios does not depend on sample mass and changes in moisture content. Therefore, this method does not require dry samples. Moreover, the use of the relations between mass fractions of chemical elements is particularly promising for the development of in vivo diagnostic methods, including the diagnosis of PCa. 

Conclusion

In this work, mean values of Br/Ca, K/Ca, Mg/Ca, Mn/Ca, and Na/Ca mass fraction ratios in normal, benign hypertrophic and cancerous prostate were calculated using data of INAA-SLR. It was observed that in benign hypertrophic tissues the Br/Ca, Mg/Ca, Mn/Ca, and Na/Ca mass fraction ratios do not differ from normal levels while the K/Ca ratio is rather higher. In cancerous tissue the Br/Ca, K/Ca, Mn/Ca, and Na/Ca ratios are significantly higher than in normal and benign hypertrophic prostate. It was shown that the Br/Ca and Mn/Ca mass fraction ratios are the most informative for a differential diagnosis among all investigated mass fraction ratios. Finally, we propose to use the estimation of Mn/Ca mass fraction ratios in a needle-biopsy core as an accurate tool to diagnose prostate cancer.

Acknowledgements

We are grateful to Dr. Tatyana Sviridova, Medical Radiological Research Center, Obninsk, and to the late Prof. A.A. Zhavoronkov, Institute of Human Morphology, Russian Academy of Medical Sciences, Moscow, for supplying prostate samples.

 

 

Figure 1: Individual data sets for Br, Ca, K, Mg, Mn, and Na mass fractions in samples of normal (1), benign hypertrophic (2) and cancerous (3) prostate. 

 

Tissue

 

Mean

 

SD

 

SEM

 

Min

 

Max

 

Median

 

Per.

 

Per.

Mass fraction ratio

0.025

0.975

Normal (n=37)

               

(Br/Ca)·102

1.44

0.9

0.21

0.333

4

1.36

0.436

3.69

K/Ca

5.69

1.74

0.38

2.5

8.23

5.92

2.52

8.2

Mg/Ca

0.511

0.211

0.045

0.229

1.03

0.449

0.242

0.932

(Mn/Ca)·103

0.623

0.256

0.062

0.1

1.078

0.592

0.192

1.05

Na/Ca

5.58

2.24

0.48

1.73

10.6

5.51

2.29

10.3

BPH (n=11)

               

(Br/Ca)·102

1.76

1.11

0.33

0.454

3.65

1.7

0.519

3.55

K/Ca

7.69

2.69

0.81

4.62

12.2

7.14

4.79

12

Mg/Ca

0.613

0.148

0.045

0.397

0.871

0.574

0.424

0.868

(Mn/Ca)·103

0.626

0.228

0.069

0.335

1.03

0.591

0.357

1.01

Na/Ca

6.21

2.33

0.7

3.02

9.25

6.66

3.03

9.07

PCa (n=11)

               

(Br/Ca)·102

18.8

10.1

3

1.52

34.1

18.8

3.21

33.4

K/Ca

13.5

3.76

1.14

7.22

18.2

13.9

7.73

18.1

Mg/Ca

0.508

0.271

0.086

0.169

1.04

0.463

0.192

0.989

(Mn/Ca)·103

11.2

6.9

2.1

1.3

22.3

11

1.66

21.5

Na/Ca

11.8

3.8

1.2

4.67

17.2

11.1

5.39

16.8

M - arithmetic mean; SD – standard deviation; SEM – standard error of mean; Min – minimum value; Max – maximum value; Per. 0.025 – percentile with 0.025 level; Per. 0.975 – percentile with 0.975 level, n - number of samples.

 

Table 1: Some statistical parameters of Br/Ca, K/Ca, Mg/Ca, Mn/Ca, and Na/Ca mass fraction ratios in normal, benign hypertrophic and cancerous prostate.

 

 

Mass fraction ratio

 

BPHand Normal (N)

 

 

PCa and Normal (N)

 

 

PCa and BPH

 

Ratio

Student’s

Ratio

Student’s

Ratio

Student’s

BPH/N

t-test

PCa/N

t-test

PCa/BPH

t-test

(Br/Ca)·102

1.22

p=0.44

13.1

p=0.00019

10.7

p=0.00022

K/Ca

1.35

p=0.041

2.37

p=0.000026

1.76

p=0.00060

Mg/Ca

1.2

p=0.12

0.99

p=0.63

0.83

p=0.16

(Mn/Ca)·103

1

p=0.97

18

p=0.00051

17.9

p=0.00051

Na/Ca

1.11

p=0.46

2.11

p=0.00021

1.9

p=0.00069

 

Table 2: Ratio of means and the reliability of difference between mean values of Br/Ca, K/Ca, Mg/Ca, Mn/Ca, and Na/Ca mass fraction ratios in normal, benign hypertrophic and cancerous prostate

  1. Kirby RS (2000) The natural history of benign prostatic hyperplasia: what have we learned in the last decade? Urology 56: 3-6.
  2. Roehrborn C and McConnell J (2002) Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. Campbell’s Urology pp: 1297-1336.
  3. Lepor H (2005) Pathophysiology of benign prostatic hyperplasia in the aging male population. Rev Urol7: S3-S12.
  4. Oliver SE, Gunnell D, Donovan JL (2000) Comparison of trends in prostate-cancer mortality in England and Wales and the USA. Lancet 355: 1788-1789.
  5. Kumar RJ, Barqawi AB, Crawford ED (2004) Epidemiology of prostate cancer. Business Briefing: US Oncology Review pp: 1-6.
  6. Maddams J, Brewster D, Gavin A, Steward J, Elliott J, et al. (2009) Cancer prevalence in the United Kingdom: estimates for 2008. Br J Cancer 101: 541-547.
  7. Lutz JM, Francisci S, Mugno E, Usel M, Pompe-Kirn V, et al. (2003) Cancer prevalence in Central Europe: the EUROPREVAL Study. Ann Oncol 14: 313-322.
  8. Möller T, Anderson H, Aareleid T, Hakulinen T, Storm H, et al. (2003) Cancer prevalence in Northern Europe: the EUROPREVAL study. Ann Oncol 14: 946-957.
  9. De Angelis R, Grande E, Inghelmann R, Francisci S, Micheli A, et al. (2007) Cancer prevalence estimates in Italy from 1970 to 2010. Tumori 93: 392-397.
  10. Waalkes MP, Rehm S (1994) Cadmium and prostate cancer. J Toxicol Environ Health 43: 251-269.
  11. Zaichick V, Zaichick S (1999) Role of zinc in prostate cancerogenesis pp:104-115.
  12. Platz EA, Helzlsouer KJ (2001) Selenium, zinc, and prostate cancer. Epidemiol Rev 23: 93-101.
  13. Zaichick V (2004) INAA and EDXRF applications in the age dynamics assessment of Zn content and distribution in the normal human prostate. J Radioanal Nucl Chem 262: 229-234.
  14. Gray MA, Centeno JA, Slaney DP, Ejnik JW, Todorov T, et al. (2005) Environmental exposure to trace elements and prostate cancer in three New Zealand ethnic groups. Int J Environ Res Public Health 2: 374-384.
  15. Zaichick S and Zaichick V (2011) INAA application in the age dynamics assessment of Br, Ca, Cl, K, Mg, Mn, and Na content in the normal human prostate. J Radioanal Nucl Chem 288: 197-202.
  16. Zaichick S and Zaichick V (2011) The effect of age on Ag, Co, Cr, Fe, Hg, Sb, Sc, Se, and Zn contents in intact human prostate investigated by neutron activation analysis. Appl Radiat Isot 69: 827-833.
  17. Zaichick S and Zaichick V (2011) The Br, Fe, Rb, Sr, and Zn content and interrelation in intact and morphologic normal prostate tissue of adult men investigated by energy dispersive X-ray fluorescent analysis. X-Ray Spectrom 40: 464-469.
  18. Zaichick V, Nosenko S, Moskvina I (2012) The effect of age on 12 chemical element contents in intact prostate of adult men investigated by inductively coupled plasma atomic emission spectrometry. Biol Trace Elem Res 147: 49-58.
  19. Zaichick S and Zaichick V, Nosenko S, Moskvina I (2012) Mass Fractions of 52 Trace Elements and Zinc Trace Element Content Ratios in Intact Human Prostates Investigated by Inductively Coupled Plasma Mass Spectrometry. Biol Trace Elem Res 149: 171-183.
  20. Zaichick V and Zaichick S (2014) Age-related histological and zinc content changes in adult nonhyperplastic prostate glands. Age 36: 167-181.
  21. Zaichick V and Zaichick S (2014) INAA application in the assessment of chemical element mass fractions in adult and geriatric prostate glands. Appl Radiat Isot 90: 62-73.
  22. Zaichick V and Zaichick S (2014) Determination of trace elements in adults and geriatric prostate combining neutron activation with inductively coupled plasma atomic emission spectrometry. Open Journal of Biochemistry 1: 16-33.
  23. Zaichick V and Zaichick S (2014) Use of INAA and ICP-MS for the assessment of trace element mass fractions in adult and geriatric prostate. J Radioanal Nucl Chem 301: 383-397.
  24. Zaichick V (2015) The variation with age of 67 macro- and microelement contents in nonhyperplastic prostate glands of adult and elderly males investigated by nuclear analytical and related methods. Biol Trace Elem Res 168: 44-60.
  25. Zaichick V and Zaichick S (2015) Dietary intake of minerals and prostate cancer: insights into problem based on the chemical element contents in the prostate gland. J Aging Res Clin Practice 4: 164-171.
  26. Zaichick V and Zaichick S (2015) Global contamination from uranium: insights into problem based on the uranium content in the human prostate gland. J Environ Health Sci 1: 1-5.
  27. Zaichick V and Zaichick S (2016) Variations in concentration and distribution of several androgen-dependent and -independent trace elements in nonhyperplastic prostate gland tissue throughout adulthood. J Androl Gynaecol 4: 1-10.
  28. Zaichick V and Zaichick S (2016) Age-related changes in concentration and histological distribution of Br, Ca, Cl, K, Mg, Mn, and Na in nonhyperplastic prostate of adults. European Journal of Biology and Medical Science Research 4: 31-48.
  29. Zaichick V and Zaichick S (2016) Variations in concentration and histological distribution of Ag, Co, Cr, Fe, Hg, Rb, Sb, Sc, Se, and Zn in nonhyperplastic prostate gland throughout adulthood. Jacobs Journal of Cell and Molecular Biology 11: 1-16.
  30. Zaichick V (2006) Medical elementology as a new scientific discipline. J Radioanal Nucl Chem 269: 303-309.
  31. Schwartz MK (1975) Role of trace elements in cancer. Cancer Res 35: 3481-3487.
  32. Kubo H, Hashimoto S, Ishibashi A, Chiba R, Yokota H (1976) Simultaneous determinations of Fe, Cu, Zn, and Br concentrations in human tissue sections. Medical Physics 3: 204-209.
  33. Forssen A (1972) Inorganic elements in the human body. I. Occurrence of Ba, Br, Ca, Cd, Cs, Cu, K, Mn, Ni, Sn, Sr, Y and Zn in the human body. Ann Med Exp Biol 50: 99-162.
  34. Holm W, Schneider H-J, Anke M (1971) Der Mineralstoffgehalt des Ejakulates und seine Beziehung zum Mengen- und Spurenelementgehalt von Prostate, Samenblase, Nebenhoden und Hoden. Arch Exper Vet Med 25: 811-815.
  35. Tohno S, Kobayashi M, Shimizu H, Tohno Y, Suwannahoy P, et al. (2009) Age-related changes of the concentrations of select elements in the prostates of Japanese. Biol Trace Elem Res 127: 211-227.
  36. Leitão RG, Palumbo A, Souza PAVR, Pereira GR, Canellas CGL, et al. (2014) Elemental concentration analysis in prostate tissues using total reflection X-ray fluorescence. Radiation Physics and Chemistry 95: 62-64.
  37. Marezynska A, Kulpa J, Lenko J (1983) The concentration of zinc in relation to fundamental elements in the diseases human prostate. Int Urol Nephrol 15: 257-265.
  38. Schneider H-J, Anke M, Holm W (1970) The inorganic components of testicle, epididymis, seminal vesicle, prostate and ejaculate of young men. Int Urol Nephrol 2: 419-427.
  39. BanaÅ› A, Kwiatek WM, ZajÄ…c W (2001) Trace element analysis of tissue section by means of synchrotron radiation: the use of GNUPLOT for SPIXE spectra analysis. Journal of Alloys and Compounds 328: 135-138.
  40. Soman SD, Joseph KT, Raut SJ, Mulay GD, Parameswaran M, Pandey VK (1970) Studies of major and trace element content in human tissues. Health Phys 19: 641-656.
  41. Guntupalli JNR, Padala S, Gummuluri AVRM, Muktineni RK, Byreddy SR,et al. (2007) Trace elemental analysis of normal, benign hypertrophic and cancerous tissues of the prostate gland using the particle-induced X-ray emission technique.Eur J Cancer Prev 16: 108-115.
  42. Leitão RG, Palumbo AJ, Correia R C, Souza PAVR, Canellas CGL, et al. (2009) Elemental concentration analysis in Benign Prostatic Hyperplasia tissue cultures by SR-TXRF. Brazilian Synchrotron Light Laboratory pp: 1-2.
  43. Kwiatek WM, Banas A, Gajda M, Gałka M, Pawlicki B, et al. (2005) Cancerous tissues analyzed by SRIXE. Journal of Alloys and Compounds 401: 173-177.
  44. Picurelli L, Olcina PV, Roig MD, Ferrer J (1991) Determination of Fe, Mg, Cu, and Zn in normal and pathological prostatic tissue. Actas Urol Esp 15: 344-350.
  45. Györkey F, Min K-W, Huff JA, Györkey P (1967) Zinc and magnesium in human prostate gland: Normal, hyperplastic, and neoplastic. Cancer Res 27: 1349-1353.
  46. Hienzsch E, Schneider H-J, Anke M (1970) Vergleichende Untersuchungen zum Mengen- und Spurenelementgehalt der normalen Prostata, des Prostataadenoms und des Prostatakarzinoms. Zeitschrift für Urologie und Nephrologie 63: 543-546.
  47. Yaman M, Atici D, Bakirdere S, Akdeniz I (2005) Comparison of trace metal concentrations in malignant and benign human prostate. J Med Chem 48: 630-634.
  48. Zaichick V and Zaichick S (2015) Differences and relationships between morphometric parameters and zinc content in nonhyperplastic and hyperplastic prostate glands. British Journal of Medicine and Medical Research 8: 692-706.
  49. Zaichick V and Zaichick S (2016) Trace element contents in adenocarcinoma of human prostate investigated by energy dispersive X-ray fluorescent analysis. Journal of Adenocarcinoma 1: 1-7.
  50. Zaichick V and Zaichick S (2016) The Bromine, Calcium, Potassium, Magnesium, Manganese, and Sodium Contents in Adenocarcinoma of Human Prostate Gland. J Hematology and Oncology Research 2: 1-12.
  51. Zaichick V and Zaichick S (2016) Trace element contents in adenocarcinoma of the human prostate gland investigated by neutron activation analysis. Cancer Research and Oncology 1: 1-10.
  52. Zaichick V and Zaichick S (2016) Prostatic tissue levels of 43 trace elements in patients with prostate adenocarcinoma. Cancer and Clinical Oncology 5: 79-94.
  53. Zaichick V and Zaichick S (2016) Chemical elemental content / Calcium ratios in tissues of human hyperplastic prostate gland.Journal of Applied Life Sciences International 4: 1-11.
  54. Zaichick V and Zaichick S, Davydov G (2015) Differences between chemical element contents in hyperplastic and nonhyperplastic prostate glands investigated by neutron activation analysis. Biol Trace Elem Res 164: 25-35.
  55. Zaichick V and Zaichick S (2016) Prostatic tissue level of some major and trace elements in patients with BPH. Jacobs Journal of Nephrology and Urology 3: 1-10.
  56. Zaichick V and Zaichick S (2016) Levels of 43 Trace Elements in Hyperplastic Prostate Tissues. British Journal of Medicine and Medical Research 15: 1-12.
  57. Zaichick V, Sviridova T, Zaichick S (1997) Zinc in human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol 29: 565-574.
  58. Zaichick S and Zaichick V (2012) Trace elements of normal, benign hypertrophic and cancerous tissues of the human prostate gland investigated by neutron activation analysis. Appl Radiat Isot 70: 81-87.
  59. Zaichick V (1997) Sampling, sample storage and preparation of biomaterials for INAA in clinical medicine, occupational and environmental health. In: Harmonization of Health-Related Environmental Measurements Using Nuclear and Isotopic Techniques. IAEA, Vienna pp: 123-133.
  60. Zaichick V and Zaichick S (1996) Instrumental effect on the contamination of biomedical samples in the course of sampling. The Journal of Analytical Chemistry 51: 1200-1205.
  61. Zaichick V and Zaichick S (1997) A search for losses of chemical elements during freeze-drying of biological materials. J Radioanal Nucl Chem 218: 249-253.
  62. Zaichick V (2004) Losses of chemical elements in biological samples under the dry aching process. Trace Elements in Medicine 5: 17-22.
  63. Zaichick V (1995) Applications of synthetic reference materials in the medical Radiological Research Centre. Fresenius J Anal Chem 352: 219-223.
  64. Korelo AM, Zaichick V (1993) Software to optimize the multielement INAA of medical and environmental samples. In: Activation Analysis in Environment Protection. Joint Institute for Nuclear Research, Dubna, Russia pp: 326-332.
  65. Catalona WJ (1996) Clinical utility of measurements of free and total prostate-specific antigen (PSA): A review. Prostate 7: 64-69.
  66. Genes VS (1967) Simple methods for cybernetic data treatment of diagnostic and physiological studies. Nauka, Moscow

 Citation: Zaichick V and Zaichick S (2016) Distinguishing Malignant from Benign Prostate Using Chemical Elemental Content / Calcium Ratios in Prostatic Tissue. Gavin J Oncol Res Ther 2016: JONT-107. DOI: 10.29011/2574-710X.000007

free instagram followers instagram takipçi hilesi